American College of Physicians issues guideline for treating low bone density or osteoporosis to prevent fractures in women and men
About 50 percent of Americans older than 50 are at risk for osteoporotic fracture
Philadelphia, May 9, 2017 -- The American College of Physicians (ACP) recommends in an evidence-based clinical practice guideline published today in Annals of Internal Medicine that physicians treat women with osteoporosis with bisphosphonates (alendronate, risedronate, or zoledronic acid) or denosumab, a biologic agent.